Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/11/16 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
15 | |
| 12/09/15 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
14 | |
| 12/08/15 | EFFECT | Notice of Effectiveness |
|
1 | |
| 12/07/15 | S-3/A | Registration statement for specified transactions by certain issuers |
|
22 | |
| 11/17/15 | 8-K | Current report filing |
|
36 | |
| 11/16/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
55 |
| 10/19/15 | 8-K | Current report filing |
|
6 | |
| 10/14/15 | S-3 | Registration statement for specified transactions by certain issuers |
|
24 | |
| 10/14/15 | 8-K | Current report filing |
|
4 | |
| 10/05/15 | 8-K | Current report filing |
|
28 |
